CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Cubist Pharmaceuticals Inc. v. Teva Parenteral Medicines Inc.

1:09-cv-00189

Overview

Case Number 1:09-cv-00189
Filing Date 2009-03-23
Status Terminated
Termination Date 2011-04-11
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Teva Parenteral Medicines Inc. Operating Company

Represented By

8 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Michael Beck

Email: mbeck@paulweiss.com

Charles H. Sanders

Email: charles.sanders@lw.com

Doungamon Fon Muttamara-Walker

District of Columbia Office of

Tel: +1 (240) 447-9752

Administrative Hearings, 441 Fourth Street, N.W.

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Laurie S. Gill

Email: lgill@goodwinprocter.com

Lauren M. Nowierski

Email: lnowierski@goodwinprocter.com

Francis C. Lynch

Email: flynch@goodwinproctor.com

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

5 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Michael Beck

Email: mbeck@paulweiss.com

Doungamon Fon Muttamara-Walker

District of Columbia Office of

Tel: +1 (240) 447-9752

Administrative Hearings, 441 Fourth Street, N.W.

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Lauren M. Nowierski

Email: lnowierski@goodwinprocter.com

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

4 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Michael Beck

Email: mbeck@paulweiss.com

Richard L. Horwitz

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Lauren M. Nowierski

Email: lnowierski@goodwinprocter.com

Plaintiff

Cubist Pharmaceuticals Inc. Operating Company

Represented By

6 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

William F. Lee

Email: William.Lee@wilmerhale.com

Lisa J. Pirozzolo

Email: lisa.pirozzolo@wilmerhale.com

Michael R. Heyison

Email: michael.heyison@wilmerhale.com

Kate Hutchins

UNDELIVERABLE EMAIL 3/14/14

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 7 proceedings
🏛️
USPTO PTAB Trials 4 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (11 found):
PTAB: 4 U.S. Courts: 7
USPTO PTAB Trial 2014-11-03
IPR2015-00227

Fresenius-Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.

U.S. Continuation Sibling (6468967)
Status: Final Written Decision
USPTO PTAB Trial 2014-11-03
IPR2015-00223

Fresenius-Kabi USA LLC v. Cubist Pharmaceuticals LLC et al.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2014-10-23
IPR2015-00132

Agila Specialties Inc. et al. v. Cubist Pharmaceuticals Incorporated et al.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2014-10-23
IPR2015-00131

Agila Specialties Inc. et al. v. Cubist Pharmaceuticals, Inc. et al.

U.S. Continuation Sibling (6468967)
Status: Institution Denied
U.S. District Court 2016-02-10
1:16-cv-00072

Cubist Pharmaceuticals LLC v. Crane Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2016-01-21
1:16-cv-00030

Cubist Pharmaceuticals LLC v. Dr. Reddys Laboratories, Ltd.

Asserted Patent
Status: DED
U.S. District Court 2015-12-29
1:15-cv-01214

Cubist Pharmaceuticals LLC v. Actavis LLC

Asserted Patent
Status: DED
U.S. District Court 2015-12-17
1:15-cv-01164

Cubist Pharmaceuticals LLC v. Sagent Pharmaceuticals, Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-07-11
1:14-cv-00914

Cubist Pharmaceuticals Inc. v. Fresenius Kabi USA LLC

Asserted Patent
Status: DED
U.S. District Court 2013-10-09
1:13-cv-01679

Cubist Pharmaceuticals LLC. v. Mylan Laboratories Limited

U.S. Family Sibling (["US8058238", "US8129342", "US6468967"])
Status: DED
U.S. District Court 2012-03-21
1:12-cv-00367

Cubist Pharmaceuticals Inc. v. Hospira Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

3 Patents

There are 3 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6468967
Methods for administration of antibiotics
Filed: 1999-09-24
Issued: 2002-10-22
Expired (Term Ended)
Expires: 2019-09-24
US6852689
Methods for administration of antibiotics
Filed: 2002-02-20
Issued: 2005-02-08
Expired (Term Ended)
Expires: 2022-02-20
USRE39071
Anhydro-and isomer-a-21978c cyclic peptides
Filed: 2000-04-11
Issued: 2006-04-18
Expired (Term Ended)
Expires: 2020-04-11

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 3

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION OPENING BRIEF filed by Teva Parenteral Medicines Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc.. (Horwitz, Richard)...
Entry #36 • 2010-04-09 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION OPENING BRIEF filed by Cubist Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 04/09/2010)
Entry #37 • 2010-04-09 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Cubist Pharmaceuticals Inc.. (Blumenfeld, Jack) (Entered: 03/19/2010)
Entry #31 • 2010-03-19 Document →

Docket Entries

(40 total)
Pleading / Complaint

COMPLAINT filed against Teva Parenteral Medicines Inc., Teva Pharmaceuticals USA Inc., Teva Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 03110000000000565096.) - filed by Cubist Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Civil Cover Sheet)(fms) (Entered: 03/24/2009)

Entry #1 • 2009-03-23
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (fms) (Entered: 03/24/2009)

Entry #2 • 2009-03-23
1

Disclosure Statement pursuant to Rule 7.1 filed by Cubist Pharmaceuticals Inc. - has no parent corporation and Federated Investors, Inc. owns more than 10% of Cubist's stock. (fms) (Entered: 03/24/2009)

Entry #3 • 2009-03-23
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,468,967 B1; 6,852,689 B2; RE39,071 E; (fms) (Entered: 03/24/2009)

Entry #4 • 2009-03-23
1
Pleading / Complaint

SUMMONS Returned Executed by Cubist Pharmaceuticals Inc.. Teva Parenteral Medicines Inc. served on 3/23/2009, answer due 4/13/2009. (Noreika, Maryellen) (Entered: 03/24/2009)

Entry #5 • 2009-03-24
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc